Diane L. Parks's most recent trade in Celularity Inc - Ordinary Shares - Class A was a trade of 30,000 Class A Common Stock done . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 30,000 | 520,021 | - | 0 | Class A Common Stock | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 30,000 | 520,021 | - | 0 | Class A Common Stock | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2025 | 156,250 | 518,774 | - | - | Stock Options | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2025 | 125,000 | 490,021 | - | 0 | Class A Common Stock | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 67,416 | 365,021 | - | 0 | Class A Common Stock | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 61,539 | 365,021 | - | 0 | Class A Common Stock | |
| Soligenix Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 17,647 | 17,647 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 28,500 | 28,500 | - | - | Option to purchase common stock | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 84,746 | 362,524 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 67,416 | 303,482 | - | 0 | Class A Common Stock | |
| Soligenix Inc | Diane Parks L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 8,646 | 8,646 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Soligenix Inc | Parks L. Diane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 38,136 | 38,136 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Soligenix Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 46,154 | 112,504 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Soligenix Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2021 | 29,126 | 29,126 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock |